Minerva Neurosciences (NERV) Stock Chart & Stock Price History → The #1 Crypto for AI (From Weiss Ratings) (Ad) Free NERV Stock Alerts $2.37 +0.02 (+0.85%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaSustainability Minerva Neurosciences Stock Price Performance5 Day Performance-1.66%1 Month Performance-6.32%3 Month Performance-74.89%6 Month Performance-56.99%Year-To-Date Performance-61.46%1 Year Performance-48.59% Receive NERV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Colonial MetalsThe asset beating inflation by 4x"Trump Loophole" Beats Inflation? Inflation has been out of control for years. Forcing you to work longer and harder for more money that is worth less. By using the "Trump Loophole", you can use a special retirement account to buy gold — and other precious metals — without taxes or penalties.That's why we have released our Free Precious Metals Investment Guide that explains all the details NERV Stock Chart for Saturday, May, 4, 2024 NERV Chart by TradingView Minerva Neurosciences Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$2.35$2.37+0.85%$2.41$2.3615,458 shs$16.57 million05/02/2024$2.40$2.35-2.08%$2.44$2.338,821 shs$16.43 million05/01/2024$2.36$2.40+1.70%$2.41$2.3115,775 shs$16.78 million04/30/2024$2.41$2.36-2.08%$2.40$2.3419,262 shs$16.50 million04/29/2024$2.44$2.41-1.09%$2.48$2.4110,961 shs$16.85 million04/26/2024$2.45$2.44-0.55%$2.49$2.434,157 shs$17.03 million Get the Latest News and Ratings for NERV and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$2.52$2.45-2.78%$2.51$2.435,770 shs$17.13 million04/24/2024$2.53$2.52-0.40%$2.53$2.473,943 shs$17.62 million04/23/2024$2.55$2.53-0.78%$2.59$2.494,576 shs$17.69 million04/22/2024$2.48$2.55+2.82%$2.58$2.4410,036 shs$17.82 million04/19/2024$2.51$2.48-1.20%$2.53$2.4511,384 shs$17.34 million04/18/2024$2.47$2.51+1.62%$2.52$2.3914,192 shs$17.55 million04/17/2024$2.50$2.47-1.20%$2.55$2.4015,670 shs$17.27 million04/16/2024$2.42$2.50+3.31%$2.80$2.3568,552 shs$17.48 million04/15/2024$2.50$2.42-3.20%$2.50$2.2930,348 shs$16.92 million04/12/2024$2.54$2.50-1.57%$2.57$2.4515,182 shs$17.48 million04/11/2024$2.47$2.54+2.83%$2.57$2.4114,230 shs$17.76 million04/10/2024$2.54$2.47-2.76%$2.53$2.437,637 shs$17.27 million04/09/2024$2.54$2.54$2.54$2.4523,444 shs$17.76 million04/08/2024$2.54$2.54$2.54$2.4910,380 shs$17.76 million04/05/2024$2.53$2.54+0.40%$2.56$2.4247,245 shs$17.76 million04/04/2024$2.54$2.53-0.39%$2.59$2.499,670 shs$17.69 million04/03/2024$2.52$2.54+0.99%$2.58$2.4715,263 shs$17.76 million04/02/2024$2.56$2.52-1.76%$2.55$2.4810,195 shs$17.58 million04/01/2024$2.58$2.56-0.78%$2.61$2.519,530 shs$17.89 million03/29/2024$2.58$2.58$2.59$2.4528,283 shs$18.03 million03/28/2024$2.52$2.58+2.38%$2.58$2.4528,283 shs$18.03 million03/27/2024$2.57$2.52-1.95%$2.62$2.4434,727 shs$17.62 million03/26/2024$2.66$2.57-3.38%$2.65$2.5236,787 shs$17.96 million03/25/2024$2.67$2.66-0.37%$2.75$2.6012,238 shs$18.59 million03/22/2024$2.59$2.67+3.09%$2.68$2.5728,421 shs$18.66 million03/21/2024$2.70$2.59-4.07%$2.78$2.5634,416 shs$18.10 million03/20/2024$2.65$2.70+1.89%$2.77$2.6324,079 shs$18.88 million03/19/2024$2.70$2.65-1.85%$2.78$2.6516,339 shs$18.52 million03/18/2024$2.79$2.70-3.23%$2.85$2.6640,771 shs$18.87 million03/15/2024$2.75$2.79+1.45%$2.80$2.7559,128 shs$19.51 million03/14/2024$2.82$2.75-2.48%$2.78$2.7059,427 shs$19.22 million03/13/2024$2.77$2.82+1.81%$2.92$2.7578,912 shs$19.71 million03/12/2024$2.81$2.77-1.42%$2.91$2.67170,350 shs$19.36 million03/11/2024$2.80$2.81+0.36%$2.91$2.60295,722 shs$19.64 millionConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold.03/08/2024$2.56$2.80+9.37%$2.87$2.54200,248 shs$19.57 million03/07/2024$2.60$2.56-1.54%$2.63$2.5366,971 shs$17.89 million03/06/2024$2.60$2.60$2.69$2.5453,790 shs$18.17 million03/05/2024$2.58$2.60+0.78%$2.63$2.4890,611 shs$18.17 million03/04/2024$2.63$2.58-1.90%$2.65$2.47153,505 shs$18.03 million03/01/2024$2.67$2.63-1.50%$2.81$2.40730,175 shs$18.39 million02/29/2024$2.83$2.67-5.65%$3.03$2.66239,995 shs$18.66 million02/28/2024$2.80$2.83+1.07%$3.19$2.78438,458 shs$19.78 million02/27/2024$6.80$2.80-58.82%$3.40$2.631.93 million shs$19.57 million02/26/2024$6.87$6.80-1.02%$7.53$6.55405,397 shs$47.53 million02/23/2024$7.25$6.87-5.24%$8.20$5.81418,464 shs$48.02 million02/22/2024$8.80$7.25-17.61%$9.40$7.00206,092 shs$50.68 million02/21/2024$8.80$8.80$9.28$8.5388,700 shs$61.51 million02/20/2024$8.39$8.80+4.89%$9.09$8.4734,182 shs$61.51 million02/19/2024$8.39$8.39$9.84$8.1859,600 shs$58.65 million02/16/2024$9.40$8.39-10.74%$9.84$8.1859,012 shs$58.65 million02/15/2024$9.85$9.40-4.57%$9.84$9.2536,227 shs$65.71 million02/14/2024$9.40$9.85+4.79%$10.18$9.2348,794 shs$68.85 million02/13/2024$9.73$9.40-3.39%$10.21$9.2022,238 shs$65.71 million02/12/2024$10.33$9.73-5.81%$10.33$9.7332,885 shs$68.01 million02/09/2024$9.52$10.33+8.51%$10.75$9.5163,907 shs$72.21 million02/08/2024$10.76$9.52-11.52%$10.88$7.89231,894 shs$66.55 million02/07/2024$12.47$10.76-13.71%$13.49$10.66208,955 shs$75.21 million02/06/2024$10.79$12.47+15.57%$12.94$10.95128,955 shs$87.17 million02/05/2024$9.44$10.79+14.30%$12.48$9.51163,046 shs$75.42 million Related Companies: VBI Vaccines Stock Price Chart NeuroBo Pharmaceuticals Stock Price Chart Cocrystal Pharma Stock Price Chart FSD Pharma Stock Price Chart Aytu BioPharma Stock Price Chart Orgenesis Stock Price Chart Vaxxinity Stock Price Chart Talphera Stock Price Chart Avalo Therapeutics Stock Price Chart Vincerx Pharma Stock Price Chart Receive NERV Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Minerva Neurosciences and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NERV) was last updated on 5/4/2024 by MarketBeat.com Staff From Our PartnersElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCGlobal crypto currency reset (41 major banks signed up)Stansberry ResearchCould Your Accounts Be Frozen?Allegiance GoldThe Gold Grab of the CenturyColonial MetalsStock-Picking AI Predicts #1 Stock of 2024AltimetryBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressThe only AI company you should be looking atBehind the Markets Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Minerva Neurosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.